leisure time -WSS

leisure time

author：hotspot 2025-10-04 06:15:43 - browse：63224

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Judge denies Trump's request for new trial in E. Jean Carroll case

knowledge

WSS

Amazon expands telehealth clinic nationwide

New safety details link Apellis eye drug to rare cases of blindness

What the airline industry can learn from medicine

What the US credit downgrade means for the economy, your finances

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

EQRx, failed developer of low

focus

leisure time

knowledge

Alkermes shareholders re

New safety details link Apellis eye drug to rare cases of blindness

Continuity nursing helped my family in our darkest PICU moments

Lawsuit alleges UnitedHealth Group unit illegally denied claims

United colonoscopy coverage change 'may cost lives,' doctors say

Are infertility treatments 'essential' during the Covid

How to save PrEP access — and even expand it

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Cancer drug shortages should be causing more outrage

A new ‘biological computer' targets cancer while sparing healthy cells

explore

Vertex non

Judge denies Trump's request for new trial in E. Jean Carroll case

The high personal cost of affirmative action for Black doctors

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

What the airline industry can learn from medicine

Delta passengers in Vegas fall sick while waiting on flight in triple

knowledge

leisure time

focus

knowledge